Floatz logo

Cyclophosphamide

Cancer-related Fatigue

PhytoHealth CorporationSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Cancer-related Fatigue cohort.

Asset / SponsorPhaseRating
Epirubicin
PhytoHealth Corporation
Phase 2B
ASTRAGALUS MEMBRANACEUS ROOT POLYSACCHARIDES
PhytoHealth Corporation
Phase 2B
pg2 lyo.
PhytoHealth Corporation
Phase 2CCC
Codonopsis
Zhejiang Provincial People's Hospital
N/AD
Zhengyuan Capsules
Qiang Fu
Phase 4NR

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →